Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Arthritis & Rheumatism

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.22119PMID 17009262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases.

  2006cited by this paper
• Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.

  2006cited by this paper
• Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus

  2005cited by this paper
• Animal models of spontaneous and drug-induced cutaneous lupus erythematosus.

  2005cited by this paper
• Optimal Use of Antimalarials in Treating Cutaneous Lupus Erythematosus

  2005cited by this paper
• Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid1

  2004cited by this paper
• Novel Mode of Action of Tylophorine Analogs as Antitumor Compounds

  2004cited by this paper
• Dermatopathological studies on skin lesions of MRL mice

  2004cited by this paper
• The Centromeric Region of Chromosome 7 from MRL Mice (Lmb3) Is an Epistatic Modifier of Fas for Autoimmune Disease Expression1

  2004cited by this paper
• Repeated α-Galactosylceramide Administration Results in Expansion of NK T Cells and Alleviates Inflammatory Dermatitis in MRL-lpr/lpr Mice 1

  2003cited by this paper
• Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice.

  2003cited by this paper
• Cutaneous lupus erythematosus: a review.

  2002cited by this paper
• Deficiency in β2-Microglobulin, But Not CD1, Accelerates Spontaneous Lupus Skin Disease While Inhibiting Nephritis in MRL-Faslpr Mice: An Example of Disease Regulation at the Organ Level1

  2001cited by this paper
• Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation

  2001cited by this paper
• Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation.

  2001cited by this paper
• Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers

  2000cited by this paper
• The central and multiple roles of B cells in lupus pathogenesis

  1999cited by this paper
• Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice.

  1998cited by this paper
• Pathogenesis of autoimmunity in αβ T cell‐deficient lupus‐prone mice

  1998cited by this paper
• Cyclosporine immunotherapy.

  1997cited by this paper
• Epidemiology and socioeconomic impact of skin disease in lupus erythematosus

  1997cited by this paper
• alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity.

  1997cited by this paper
• Enhanced and accelerated lymphoproliferation in Fas-null mice.

  1996cited by this paper
• Systemic Lupus Erythematosus

  1996cited by this paper
• Systemic lupus erythematosus.

  1996cited by this paper
• Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

  1992cited by this paper
• Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions.

  1991cited by this paper
• Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4

  1987cited by this paper
• Autoantibodies to ribonucleoproteins.

  1985cited by this paper
• Murine models of systemic lupus erythematosus.

  1985cited by this paper
• A crossover double-blind study on Tylophora indica in the treatment of asthma and allergic rhinitis.

  1969cited by this paper

• Synthesis of cis-(8b,14a)-hexahydro-14H-dibenzo[f,h]oxazolo[3,2-b]isoquinolin-14-ones via photo cascade reaction

  2024influential citation
• Design, Synthesis, Antivirus Activity, and SARs of Phenanthroquinolizidine Alkaloid Derivatives

  2021cites this paper
• Lead Optimization: Synthesis and Biological Evaluation of PBT-1 Derivatives as Novel Antitumor Agents.

  2021cites this paper
• Target-Directed Design, Synthesis, Antiviral Activity, and SARs of 9-Substituted Phenanthroindolizidine Alkaloid Derivatives.

  2021cites this paper
• Design, Synthesis and in Vitro Evaluation of Tylophorine Derivatives as Possible Antitumor Agents

  2020cites this paper
• The role of properdin in the pathogenesis of murine systemic lupus erythematosus

  2019cites this paper
• Ethno-Eco-Chem-Medico and Tissue Culture Knowledge of the Asthma Climber-Antmool (Tylophora Indica)

  2019cites this paper
• The potential impacts of tylophora alkaloids and their derivatives in modulating inflammation, viral infections, and cancer.

  2019cites this paper
• Design, Synthesis, and Antitobacco Mosaic Virus Activity of Water-Soluble Chiral Quaternary Ammonium Salts of Phenanthroindolizidines Alkaloids.

  2018cites this paper
• Microwave-assisted one-pot synthesis of new phenanthrene fused-tetrahydrodibenzo-acridinones as potential cytotoxic and apoptosis inducing agents.

  2018cites this paper
• Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies.

  2018cites this paper
• Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation and apoptosis inducing studies.

  2017cites this paper
• Synthesis of 2,3,6,7-tetramethoxyphenanthren-9-amine: An efficient precursor to access new 4-aza-2,3-dihydropyridophenanthrenes as apoptosis inducing agents.

  2017cites this paper
• P-Selectin preserves immune tolerance in mice and is reduced in human cutaneous lupus

  2017cites this paper
• Tylophorine Analogs Allosterically Regulates Heat Shock Cognate Protein 70 And Inhibits Hepatitis C Virus Replication

  2017cites this paper
• Design and synthesis of 1,2,3-triazolo-phenanthrene hybrids as cytotoxic agents.

  2017cites this paper
• Psgl-1/p-selectin interaction: Regulation of immune and vascular homeostasis

  2017cites this paper
• Tylophorine Analog DCB-3503 Inhibited Cyclin D1 Translation through Allosteric Regulation of Heat Shock Cognate Protein 70

  2016cites this paper
• Spatial Configuration and Three-Dimensional Conformation Directed Design, Synthesis, Antiviral Activity, and Structure-Activity Relationships of Phenanthroindolizidine Analogues.

  2016cites this paper
• Total Synthesis of Phenanthroindolizidine Alkaloids by Combining Iodoaminocyclization with Free Radical Cyclization.

  2016cites this paper
• Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation.

  2015cites this paper
• The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus

  2015cites this paper
• Review on the Anticancer and In-silico Binding Studies of Phenanthroindolizidine Alkaloids

  2015cites this paper
• The Design of Novel DCB-3503 Analogues: Ligand-Based and Structure-Based Approaches

  2015cites this paper
• Design, synthesis, antiviral activity, and structure-activity relationships (SARs) of two types of structurally novel phenanthroindo/quinolizidine analogues.

  2014cites this paper
• Design, synthesis, antiviral activity, and SARs of 13a-substituted phenanthroindolizidine alkaloid derivatives.

  2014cites this paper
• Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice

  2014cites this paper
• Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity.

  2014cites this paper
• Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.

  2013cites this paper
• Different salt derivatives of phenanthroindolizidine alkaloids display different in vitro antitumor activity

  2013cites this paper
• Total synthesis of phenanthroindolizidine alkaloids through an amidyl radical cascade/rearrangement reaction.

  2013cites this paper
• Synthesis and evaluation of the anti-proliferative and NF-κB activities of a library of simplified tylophorine analogs.

  2012cites this paper
• Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.

  2012cites this paper
• Cryptopleurine Analogs with Modification of E Ring Exhibit Different Mechanism to Rac-Cryptopleurine and Tylophorine

  2012cites this paper
• A novel tylophorine analog NK-007 ameliorates colitis through inhibition of innate immune response.

  2012cites this paper
• DCB-3503, a Tylophorine Analog, Inhibits Protein Synthesis through a Novel Mechanism

  2010cites this paper
• Design, synthesis, and biological studies of new phenanthroindolizidine and phenanthroquinolizidine analogs as anticancer agents

  2010cites this paper
• Vinylogous Esters and Amides: Useful Synthons for Diversity-Oriented and Natural Product Synthesis

  2009cites this paper
• NF-κB and Therapeutic Approach

  2009cites this paper
• Special Topic: NF-κB, Immunity and Cancer Targeting NF-κB: A Promising Molecular Therapy in Inflammatory Arthritis

  2008cites this paper
• Structural analogs of tylophora alkaloids may not be functional analogs.

  2008cites this paper
• Cutaneous lupus: insights into pathogenesis and disease classification.

  2007cites this paper
• Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.

  2007cites this paper
• Inhibition of cell growth and nuclear factor-κB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503

  2006cites this paper